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Background: Ending new paediatric HIV infections continues to be a global health priority. Cuba and other countries have
demonstrated that elimination of mother-to-child transmission is possible through Prevention of Mother-to-Child
Transmission (PMTCT) interventions. As Namibia works on improving PMTCT there is a need to identify the local modifiable
factors to achieve zero new HIV infections.
Aim: This study aimed to identify the modifiable factors within the PMTCT programme, which contributed to the acquisition of
HIV infection among children.
Setting: The study was carried out in the Onandjokwe District, Northern Namibia.
Methods: A descriptive audit was undertaken of 59 medical records of mothers and their children under two years, who
acquired HIV despite the PMTCT programme between 2014 and 2016.
Results: The study found that overall HIV transmission was only 2%, but 80% of the paediatric HIV infections could be prevented
by implementing the existing Namibian PMTCT recommendations. Overall 61% of modifiable factors were related to mothers,
30% to health workers and 10% to the health system. The top three modifiable factors were the mother defaulting on ART
during pregnancy or breastfeeding, the health worker not intervening when the mother failed the first-line ART regimen,
and poor coordination of care between the hospital and primary care.
Conclusion: Although overall transmission is low with the PMTCT programme, the majority of remaining HIV infections among
children under two years could be prevented by addressing the modifiable factors identified in this study.
Keywords: antenatal care, communicable disease transmission, human immunodeficiency virus, infant, Namibia, pregnancy, risk
factors
Introduction
The elimination of HIV by preventing mother-to-child trans-
mission continues to be a global health priority.1 The third
United Nations Sustainable Development Goal (SDG) includes
a commitment to end the AIDS epidemic.2 One of the major
steps in getting to zero new HIV infections is ending paediatric
HIV infections. Mother-to-child transmission has been virtually
eliminated in high-income countries and demonstrates that
the use of appropriate antiretroviral (ARV) medication during
pregnancy and breastfeeding can reduce the risk of vertical
transmission to less than 5%.3 Cuba, a low-income country,
has demonstrated that it is possible to eliminate HIV infection
in children through the Prevention of Mother-To-Child Trans-
mission (PMTCT) programme, as it became the first country cer-
tified by the World Health Organization (WHO) in 2015 to have
done so.4 To date four more countries (Thailand, Belarus,
Armenia and Moldova) have been validated by the WHO.5 Elim-
inating new HIV infections among children through the PMTCT
programme has been shown to be cost-effective as it decreases
morbidity and mortality, the psychological burden of HIV, as well
as economic costs to both individuals and society.6
The PMTCT programme has been proven to effectively reduce
the risk of transmitting HIV infection from mothers to their
babies, even in low-resource settings.7,8 The benefit of using a
short-term combination of triple ARVs in pregnant mothers
and single-dose nevirapine in exposed infants was shown to sig-
nificantly decrease the chance of a mother transmitting HIV to
her baby.9 WHO guidelines for PMTCT in 2013 and 2015 rec-
ommended starting life-long Highly Active Anti-Retroviral
Therapy (HAART) in all HIV-positive pregnant and breastfeeding
mothers and to offer nevirapine to their babies throughout the
breastfeeding period.9,10 Adoption of the new 2016 WHO guide-
line recommendations to treat everyone who tests HIV-positive
is expected to further reduce the chance that children born to
HIV-positive mothers will be HIV infected because of earlier
initiation of ARV and attainment of viral suppression.10,11 Pre-
vention of new infections through the PMTCT programme will
not only save the life of the baby, but will keep the mother
alive by giving her the treatment she needs, and protect other
children in the family from being orphaned. Ongoing efforts
to stop new HIV infections emphasise the need for frequent
monitoring of HIV viral loads among pregnant and breastfeed-
ing mothers, use of dual prophylaxis (AZT and nevirapine) for
infants at higher risk of HIV acquisition and repeated regular
HIV testing of HIV-negative mothers during the breastfeeding
period to close the remaining gaps in PMTCT.12
Namibia has implemented PMTCT since 2005 and the latest
Namibian guidelines adopt the 2016 WHO recommendations,
with a clear commitment to the elimination of mother-to-child
transmission.13 Identifying avoidable factors related to HIV trans-
mission during the PMTCT period can help the health services to
achieve this goal. Some of the known modifiable risk factors in
the PMTCT programme in sub-Saharan countries are poor
access to maternal care and/or PMTCT services due to
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geographic factors, non-availability of medication, economic
barriers such as transport costs, and unacceptable services due
to negative staff attitudes.14,15 The quality of care may also be
impaired due to a failure to offer PMTCT and/or a lack of knowl-
edge amongst healthcare professionals.16 The modifiable factors
may differ between countries and even districts within countries
and therefore local modifiable factors must be identified and
solutions developed to prevent new HIV infections in chil-
dren.17–19 This type of research has yet to be conducted in
Namibia.
A study at Onandjokwe Hospital, Namibia in 2013 showed that
13% of mothers of children less than five years old, who were
admitted and died, were not given an HIV test during pregnancy
and 15% of the children that died were confirmed HIV-positive
for the first time when admitted to the ward.20,21 From February
2014 until January 2016 a total of 67 children under two years of
age acquired HIV despite the PMTCT programme at Onandjokwe
Hospital. This study in the Onandjokwe District aimed to identify
the modifiable factors within the PMTCT programme, which con-
tributed to the acquisition of HIV infection among these chil-
dren. The identified modifiable factors can be used by PMTCT
stakeholders to design local strategies to close the gaps and
prevent new paediatric HIV infection.
Methods
Study design
The study was a descriptive audit of the medical records of
mothers and their children under two years, who acquired HIV
despite the PMTCT programme’s existence in the period 2014–
2016.
Study setting
The study was conducted at Onandjokwe District in northern
Namibia, located 750 km from the capital city of Windhoek.
Onandjokwe District covers approximately 25 000 km2 with a
catchment population of 147 000. The majority of patients live
in rural villages and walk to nearby health facilities. The district
has one referral hospital (Onandjokwe), three health centres
and eight primary care clinics.
All facilities were implementing PMTCT option B+ since 2014 as
part of antenatal care (ANC) services. The PMTCT option B+
offers all pregnant and breastfeeding women HAART as soon
as they are diagnosed, which is continued for life regardless of
CD4 count. Prior to 2014 Option A was given to pregnant
mothers who did not quality for ART.22
Onandjokwe District Hospital offers the PMTCT services via
antenatal and intrapartum care and has ARVs easily available.
Onandjokwe’s ART clinic is the third largest in the country
by patient volume and serves as the referral centre for the
rest of the 11 healthcare facilities in the district that offer
HIV services. Deliveries are all conducted at the hospital and
the primary care facilities also provide antenatal, postnatal
and HIV care. HIV testing is performed by health assistants,
who may not always be available at the clinics or at night
when emergencies are seen.
Exposed infants received nevirapine at their respective clinics
and were followed up until the age of six weeks when their
first DNA polymerase chain reaction (PCR) test was performed;
those who tested HIV-positive were referred to Onandjokwe
for confirmation and prepared for ART initiation. All children
who tested DNA PCR negative at 6 weeks continued with breast-
feeding up to 12 months while receiving nevirapine. A second
diagnostic rapid test (Determine) was performed at nine
months and repeated four weeks after stopping breast milk
exposure. Any child who tested positive by HIV rapid test was
referred to Onandjokwe Hospital for an HIV confirmatory test
and was then started on ART. All paediatric patients were
initiated on ART at Onandjokwe Hospital and monitored for at
least six months or until the first viral load result was reviewed.
Those with suppressed viral load and who were clinically stable
were then referred, with their mothers, to a nearby health facility
for continued care.
Study population
The population included all children who were confirmed HIV-
positive in the chronic care ART register, were under the age
of two years, and registered between April 1, 2014 and March
30, 2016 at Onandjokwe District Hospital. The register showed
a total of 67 children for this period.
Data collection
A standardised data collection tool was used to collect data from
each individual record on adherence to the key recommen-
dations of the PMTCT guidelines during pregnancy, delivery
and postpartum care.
The adherence to ART was assessed by healthcare workers using
pill counts, whereby patients who consumed more than 95% of
the recommended doses supplied at the last visit were regarded
as having good adherence, between 85% and 95% as having fair
adherence and those at less than 85% were classified as having
poor adherence. Any patient who missed his/her clinic visit and
interrupted ART treatment was defined as a ‘defaulter’ and
should have received counselling to avoid further interruptions.
Any patient who interrupted ART for 90 consecutive days or
more was defined as ‘lost to follow-up’ and should have been
traced, brought to care and reasons explored to prevent
future problems.13
The design of the tool was based on another study at Onand-
jokwe Hospital on the causes of mortality and associated mod-
ifiable healthcare factors for children (< 5 years).20 The tool
was submitted to a panel of experts to validate its content
and construct and was piloted on six test cases to ensure it
was practical to collect data. The tool consisted of the following
information: demographic information, PMTCT option, infant
feeding choice, date when mother initiated ARV therapy,
overall adherence to ARVs of the mother, date when the child
was confirmed HIV-positive and the HIV viral load of the mother.
Data were extracted by the principal investigator. The medical
records reviewed included the ANC registers, labour and deliv-
ery register books, maternity delivery clinical notes, postnatal
clinical notes, mother–baby care follow-up register, and ART
patient care booklets.
Data captured in the tool were then analysed by a review team
who reached a consensus on any reason(s) why the PMTCT pro-
gramme failed to prevent transmission and a judgement as to
whether the infant’s HIV infection could have been prevented.
The review team included the principal investigator, senior HIV
doctor and the district HIV clinical mentor. This team also
referred to the records themselves if necessary to clarify issues.
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Data analysis
Data were captured on an Excel spreadsheet (Microsoft Corp,
Redmond, WA, USA) and checked for any missing, incomplete
or inconsistent data before analysis. The data were analysed
by a statistician using the Statistical Package for the Social
Sciences version 16.0 (SPSS Inc, Chicago, IL, USA). Descriptive
statistics were used to determine frequencies and percentages
or means and standard deviations.
Results
The study included 59 children out of the possible 67, due to 8
missing records. A total of 19 898 deliveries were conducted
during the study period, among whom 3 358 pregnant
mothers were HIV-positive (17%) and the transmission rate
was therefore 2%.
Of the 59 children the majority were female with a normal
vaginal delivery (Table 1). Although 42% of mothers started on
ART before pregnancy and a further 19% during pregnancy,
39% of these mothers started ART only at delivery or in the post-
natal period.
Table 2 presents the PMTCT options used and infant feeding
practices. As expected the majority of mothers received
PMTCT Option B + . One mother was still on Option A and follow-
ing the previous guidelines. The majority of infants (82%) did not
receive nevirapine as they should, 51% never received
nevirapine and a further 31% only received it at delivery.
Although 97% of mothers intended to breastfeed exclusively
only 54% actually did and 44% mixed fed their infants under
the age of 6 months.
Table 3 presents the key characteristics of mothers’ ART at the
point when their child was diagnosed with HIV. Among this
group of mothers 51% had been on ART for more than 6
months and of those 63% were poorly adherent to treatment
and 67% never had their viral load checked, mainly because
they did not attend the follow-up appointments.
Overall, 279 modifiable factors were identified and the majority
of these factors (61%) were related to the mother (Table 4). Most
of these factors were associated with poor adherence to ART in
the mother or their infant (28%), poor adherence with antenatal
care visits (13%), mixed feeding (9%) and unsafe sex (8%). In
addition, 30% of the factors were related to the clinical care pro-
vided by health professionals. Key issues in the health pro-
fessionals included a failure to check for or respond to poor
adherence to ART (19%), a delay in initiating ART in the






Normal vaginal delivery 54 91.5
Caesarean section 5 8.5
Place of delivery:
Health facility 48 81.4
Home 8 13.6
In transit 3 5.1





Time of HIV diagnosis of mothers:
Before pregnancy 29 49.2
During first trimester 3 5.1
During second trimester 5 8.5
During third trimester 5 8.5
During labour and delivery 2 3.4
During postnatal and breastfeeding 15 25.4
Time of ART initiation for mothers:
Before pregnancy 25 42.4
1st trimester 3 5.1
2nd trimester 5 8.5
3rd trimester 3 5.1
Labour and delivery 1 1.7
Postnatal and breastfeeding period 22 37.3
Table 2: PMTCT and feeding options (n = 59)
Variables n %
Mother’s PMTCT options:
Allocated to PMTCT Option A 1 1.7
Allocated to PMTCT Option B+ 43 72.9
No PMTCT allocation during pregnancy 15 25.4
Children PMTCT options:
Children received nevirapine during delivery only 18 30.8
Children received nevirapine during delivery and
breastfeeding
11 18.6
Children never received nevirapine 30 50.8
Mother’s choice of feeding option after delivery:
Breastfeeding 57 96.6
Formula milk feeding 2 3.4
Infant feeding practices:
Exclusive breastfeeding until 6 months 32 54.2
Mixed feeding 26 44.1
Formula milk 1 1.7
Table 3: Mothers’ follow-up care characteristics
Variables n %
Mother on ART follow-up ≥ 6 months (n = 59):
Yes 30 50.8
No 29 49.2




Viral load at 6 months post ART initiation (n = 30):
< 40 IU/ml 2 6.7
40–1 000 IU/ml 1 3.3
> 1 000 IU/ml 7 23.3
Viral load not done 20 66.7
Reasons for the viral load not done (n = 20):
Unknown 4 20.0
Missed follow-ups 16 80.0
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mother or prophylaxis in the infant (7%) and a failure to test for
HIV during antenatal care (4%). Only 10% of factors related to
the health system and the main factor was a lack of an effective
system to coordinate care between the hospital and the primary
care facilities (9%).
The overall consensus was that 80% of the HIV infections could
have been prevented by implementing the existing Namibian
PMTCT recommendation; 5% of infections happened despite
following the recommendations and in 15% of children it
was difficult to decide whether the infection could have
been avoided.
Discussion
The overall transmission rate was very low and suggests that the
PMTCT programme in Onandjokwe District was working well.
Amongst the 2% of pregnancies where HIV-positive mothers
transmitted the virus the majority of modifiable factors were
allocated to the mother in terms of her adherence to use of anti-
retroviral medication, antenatal care visits, mixed feeding and
unsafe sex. A number of modifiable factors were, however,
identified in the health services and system. These included a
failure to check on or respond to poor adherence in the
mother, delayed initiation of ART, failure to test for HIV and
poor coordination of care between the hospital and primary
care facilities. The proportion of infections that were judged to
be avoidable were much higher than in South Africa (80% vs.
34%),14 although the South African study did not look at adher-
ence to treatment or duration of ART.
In South Africa the majority of modifiable factors were also
related to the mothers and similarly 50% of mothers were not
aware of their HIV status at the time they fell pregnant.14 Inter-
estingly, twice as many female compared with male infants were
infected in Namibia and there is no clear explanation for this.
South Africa reported equal numbers of male and female
infected infants.14
Defaulting and poor adherence amongst mothers was a key
finding and was also reported in Malawi where 20% of patients
who initiated ART missed appointments and only 40% could be
traced.23 Overall 50% of the infants in Onandjokwe never
received nevirapine, which is slightly more than the 43%
reported in South Africa.15 This number can be partly explained
by the fact that 25% of the mothers were only diagnosed post-
natally when their children were admitted for sickness and in 6%
nevirapine was out of stock. The results can be compared to
South Africa where 26% of mothers were also tested late for
HIV.15
Mixed feeding was common (44%) and appeared much higher
than reports from South Africa (6%).15 Again differences might
be due to methodological issues; however, such high rates
may require further study and intervention.
A third of mothers attended ANC late or not at all, which could
make it difficult for mothers to test for HIV and receive a timely
PMTCT intervention. This rate, however, is lower than South
Africa, where approximately half of the mothers had their first
ANC visit in the third trimester.15 In the USA 56% did not
receive antenatal care.15,24
In addition 19% of mothers delivered either at home or on
transit to the district hospital and might have delayed or
missed the PMTCT interventions. In Malawi only 77% of
women who delivered at home could be traced to get PMTCT
interventions and none of their children were taken back to
health facilities for nevirapine prophylaxis.20
Health professionals were responsible for a failure to act on
results showing a high HIV viral load and lack of initiative from
healthcare workers to trace defaulters. Higher rates of poor
viral load monitoring have been reported in South Africa
(75%) and the USA (37%) as well as failure to take action
when a high viral load is observed.15,22 A failure to respond to
virological failure may also expose the infant to resistant HIV
strains and negate the value of nevirapine prophylaxis. Missed
opportunities to provide ART was seen in 14% of children,
almost similar to a rate of 15% in South Africa.14 Several preg-
nant mothers had a delay in the initiation of ART (8%), despite
clear Namibian ART guideline recommendations,25 although
higher rates have also been reported in South Africa, Ghana
and Kenya.6,9,15 Late maternal HIV testing puts the infant at
higher risk of HIV transmission and this issue has also been
observed in South Africa (32% of mothers) and the USA (26%
of mothers).14,15,20,24
Healthcare system gaps included a lack of coordination of care
between district hospitals and primary care facilities, such that
the mothers who were expected to come for follow-up could
not be identified easily and were not traced if they failed to
attend.
Table 4: Modifiable factors in mother-to-child transmission (n = 279)
Modifiable factors n %
Modifiable factors related to healthcare system: 27 9.7
No system for clinics to identify and follow up postnatal
mothers
25 9.0
Nevirapine out of stock 2 0.7
Modifiable factors related to healthcare professionals: 83 29.7
Patient was failing first-line ART regimen with no
intervention
36 12.9
Failed to check viral load 4 1.4
Failed to trace the patients who defaulted on ART 14 5.0
Mother attended ANC, but not offered HIV test 10 3.6
Pregnant mother tested HIV-positive, but ART initiated
later in pregnancy or only when a child tested positive
10 3.6
The new born was not given NVP until follow up at 6
weeks
8 2.9
Healthcare professionals offered HIV test very late in
pregnancy
1 0.4
Modifiable factors related to mother and children: 169 60.6
Mother defaulted on ART during pregnancy and
breastfeeding
34 12.2
Mixed feeding started before infant reached 6 months 26 9.3
Mother had high viral load before pregnancy 22 7.9
Mother defaulted on nevirapine treatment in the infant 21 7.5
Mother did not attend appointment for viral load check 16 5.7
Mother seroconverted during pregnancy or
breastfeeding
15 5.4
Mother never attended ANC 11 3.9
Mother started ANC very late, HIV test done very late 8 2.9
Mother became pregnant while preparing to start ART 8 2.9
Delivered at home 7 2.5
Mother tested positive, but refused to be initiated on
ART
1 0.4
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Limitations of the study
Not all medical records were available and additional factors
might have been identified or ranked differently if all records
were included in the study. Some of the included records
lacked sufficient information to judge whether modifiable
factors were present despite the fact that the review team also
waited for the mother–child’s follow-up visit to elicit information
from the patient’s and child’s road-to-health card. The results of
this study depend on the analysis and decision-making of the
review team. In cases where there was no consensus, for
example if the factor was primarily related to healthcare
workers or to patients, the decision was made on the opinion
of the majority of the panel. The study involved infants who
were already diagnosed with HIV and, therefore, HIV-positive
infants who were not yet diagnosed would be excluded from
the study.
Recommendations
The transmission of HIV to an infant should be seen as a critical
incident and a review of the records to identify modifiable
factors should become institutionalised and not just part of a
research study. This will enable ongoing learning and correction
of the PMTCT programme’s challenges and hopefully realisation
of the goal of zero new HIV infections by 2030.
Patient empowerment and engagement is crucial and health
education on ART should be provided at different service deliv-
ery points such as ANC, ART support counselling teams and
through the media to reduce mothers defaulting on their ART.
Comprehensive education on the PMTCT approach should
include the importance of infant nevirapine prophylaxis, early
infant diagnostic tests, feeding options, adherence to medi-
cation, and use of condoms during the breastfeeding period.
Namibia has an extensive network of health extension workers
in the community, and health facilities should work in collabor-
ation with this cadre to provide community education and sen-
sitisation on the importance of attending ANC and if possible to
plan to stay near to the health facility when they are due to
deliver.
Mothers unable to access healthcare facilities due to long dis-
tances should be assisted to create local support groups with
the help of health extension workers, whereby they can
receive ART in the community.
Not all primary care providers have attended training in HIV
testing and in some facilities patients may be referred to make
a diagnosis. Provider initiated testing and counselling (PITC) train-
ing should be made available and clinical governance should
ensure that all providers are capable of providing this service.
Services for ANC, postnatal care and HIV are still separated
within health facilities, which may also contribute to fragmenta-
tion of care. Integration of these services should improve access
to care, monitoring of viral load in the mothers and early infant
diagnosis.
To avoid children missing nevirapine the mother’s contacts
should be obtained immediately after delivery and a reminder
given by phone or health extension worker prior to their
follow-up date. Better communication and coordination of
care is needed between hospital and primary care facilities to
enable this. Each facility should have a standard operating pro-
cedure with clear steps on how to offer PMTCT services. Nevira-
pine should be available at all times; in case of no supply from
central medical stores hospital arrangements should be made
for buy-out from private pharmacies.
Conclusion
Although the overall HIV transmission rate from mothers to
infants was low, modifiable factors could have prevented trans-
mission in 80% of children that were infected. Overall 61% of
modifiable factors were related to mothers, 30% to health pro-
fessionals and 10% to the healthcare system. The key modifiable
factors related to the mother were poor adherence to ART in
themselves or their infant, poor attendance at antenatal care,
mixed feeding and unsafe sex during pregnancy. The key mod-
ifiable factors related to the health services and system were a
failure to check on or respond to poor adherence in the
mother, delayed initiation of ART, failure to test for HIV and
poor coordination of care between the hospital and primary
care facilities. The Onandjokwe district should plan interventions
to target these modifiable factors, which may also be relevant to
other health districts in Namibia.
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